Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling

Biological Chemistry

Volumn 382, Issue 1, 2001, Pages 15-22

  Chao, J ^a   Miao, R Q ^a   Chen, V ^a   Chen, L M ^a   Chao, L ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Angiogenesis; Blood pressure reduction; Kallistatin; Neointima hyperplasia; Tissue kallikrein binding protein; Vascular cell growth

Indexed keywords

KALLISTATIN; PHENYLALANINE; SERINE PROTEINASE INHIBITOR; TISSUE KALLIKREIN; UNCLASSIFIED DRUG;

ADENOVIRUS; ANGIOGENESIS; ANIMAL TISSUE; ARTERY INJURY; BALLOON; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD VESSEL; BLOOD VESSEL FUNCTION; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE TARGETING; GENETIC ENGINEERING; HINDLIMB; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPOTENSION; IN VITRO STUDY; INTIMA; ISOLATED KIDNEY; KALLIKREIN KININ SYSTEM; KIDNEY PERFUSION; LIMB ISCHEMIA; MOLECULAR CLONING; MOUSE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RAT; REVIEW; RODENT; SITE DIRECTED MUTAGENESIS; SMOOTH MUSCLE FIBER; STRUCTURE ANALYSIS; TRANSGENIC MOUSE; VASCULAR RING; VASODILATATION;

ANIMALS; BLOOD VESSELS; CARRIER PROTEINS; HUMANS; KALLIKREINS; NEOVASCULARIZATION, PATHOLOGIC; SERPINS;

ADENOVIRIDAE; ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0035115958     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2001.003     Document Type: Review

References (43)

1. 1 receptor mediated inhibition of neointima formation in rat artery after balloon angioplasty
2. Pigment, epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop
3. Bioregulation of kinins: Kallikreins, kininogens, and kininases
4. The refined 1.9 Å crytal structure of human α-thrombin: Interactions with D-Phe-Pro-Arg chloromethylketone and significance of the Tyr-Pro-Pro-trp insertion segment
5. The serpins: Evolution and adaptation in a family of protease inhibitors
6. Molecular cloning and analysis of the rat kallikrein-binding protein gene
7. Molecular cloning and sequence analysis of the mouse kallikrein-binding protein gene
8. Kallistatin: A novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli
9. A major difference of kallikrein-binding protein in spontaneously hypertensive versus normotensive rats
10. Biochemistry, regulation and potential function of kallistatin
11. Identification of a new tissue-kallikrein-binding protein
12. Tissue kallikrein-binding protein is a serpin. I. Purification, characterisation, and distribution in normotensive and spontaneously hypertensive rats
13. Kallistatin, a novel human tissue kallikrein inhibitor: Expression in blood cells and abnormal plasma level in human liver disease, spesis and preeclampsia
14. Kallistatin is a potent new vasodilator
15. 1-antitriypsin with human tissue kallikrein
16. Cellular localization of human tissue kallikrein and kallistatin by in-situ hybridization
17. Cellular localization of tissue kallikrein and kallistatin mRNAs in human kidney
18. Tissue kallikrein-binding protein reduces blood pressure in transgenic mice
19. Beneficial effects of kallikrein-binding protein in transgenic mice during endotoxic shock
20. Adenoviral-mediated delivery of human kallistatin gene reduces blood pressure of spontaneously hypertensive rats
21. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis
22. Roles of the P1, P2 and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein
23. Identification of a major heparin-binding site in kallistatin
24. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein
25. The glandular kallikrein family of enzymes: Tissue-specific expression and hormonal regulation
26. The human kallikrein gene family: A diversity of expression and function
27. Pigment epithelium-derived factor: A potent inhibitor of angiogenesis
28. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein
29. Ein neues kreislaufhormon und seine wirkung
30. Inhibition of human tissue (urinary) kallikrein by sera of patients suffering from hereditary alpha 1-antitrypsin (alpha 1-proteinase inhibitor) deficiency
31. Progressive inhibition of human glandular (urinary) kallikrein by human serum and identification of the progressive antikallikrein as alpha 1-antitrypsin (alpha 1-protease inhibitor)
32. Kinetics of heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin
33. Crystal structure of recombinant human tissue kallikrein at 2.0 Å resolution
34. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues
35. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery
36. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin
37. Heparin binding to protein C inhibitor
38. A comparison of three heparin-binding serine proteinase inhibitors
39. Activation of heparin cofactor II by dermatan sulfate
40. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands
41. Localization and expression of tissue kallikrein and kallistatin in human blood vessels
42. Maspin is an angionesis inhibitor
43. Kallistatin: A novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence